t 02 8276 6288 e enquiries@australianethical.com.au p GPO Box Centre Sydney, GPO Box 8, Sydney NSW 2001 Australian Ethical Investment Ltd ABN 47 003 188 930 AFSL 229949 australianethical.com.au 14 September 2026 Market Announcements Office ASX Limited Exchange Centre 39 Martin Place SYDNEY NSW...
Change in substantial shareholding for OSL
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Notice Under Section 708A
- Application for quotation of securities - OSL
- Australian Manufacturing Facility Achieves ISO 13485
- 100th Patient Treated with OncoSil device in Spain
- OSL Secures $5.6 million from Major Institutional Investors
Later from OncoSil Medical
- Change in substantial holding
- Notice under ASX Listing Rule 3.10A
- Notice of AGM date
- OncoSil Clinical Data to be Presented at EANM 2026
- PALACROS Officially Launched in Amsterdam
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical